SCHEMBL5155207

SCHEMBL5155207

O=C(O)[CH]NC(=O)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.57
RAB9A P51151 4/20 0.57
ALOX15 P16050 2/20 0.54
HDAC3 O15379 1/20 0.54
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
IDO1 P14902 1/20 0.54
HDAC1 Q13547 1/20 0.54
CA9 Q16790 1/20 0.54
HDAC7 Q8WUI4 1/20 0.54
HDAC2 Q92769 1/20 0.54
HSD17B10 Q99714 1/20 0.54
HDAC8 Q9BY41 1/20 0.54
HDAC6 Q9UBN7 1/20 0.54
NCOR2 Q9Y618 1/20 0.54
ALDH1A1 P00352 3/20 0.50
MAPT P10636 3/20 0.50
KMT2A Q03164 3/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10841553 0.84 NPC1 (0.59) NPC1RAB9AALOX15HDAC3CA12
SCHEMBL6960400 0.83 NPC1 (0.53) NPC1RAB9AALOX15HDAC3CA12
SCHEMBL7867083 0.79 RAB9A (0.50) NPC1RAB9AALOX15HDAC3CA12
SCHEMBL554490 0.79 RAB9A (0.59) NPC1RAB9AALOX15HDAC3CA12
SCHEMBL5912481 0.78 NPC1 (0.63) NPC1RAB9AALOX15HDAC3CA12
SCHEMBL4644708 0.77 NPC1 (0.57) NPC1RAB9AALOX15HDAC3CA12
SCHEMBL11145110 0.77 NPC1 (0.57) NPC1RAB9AALOX15HDAC3CA12
SCHEMBL497521 0.77 NPC1 (0.57) NPC1RAB9AALOX15HDAC3CA12
SCHEMBL3247733 0.77 NPC1 (0.57) NPC1RAB9AALOX15HDAC3CA12
SCHEMBL289886 0.77 NPC1 (0.57) NPC1RAB9AALOX15HDAC3CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130165446-A1 BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE HORIKOSHI, HIROYOSHI (CA) 2013-06-27 US claimed
EP-2581373-A1 BENZO- OR PYRIDO-IMIDAZOLE DERIVATIVE Fujita, Takashi (JP) 2013-04-17 EP claimed
EP-0500494-B1 Surface modified pigment compositions CIBA GEIGY AG (CH) 1995-11-15 EP claimed
US-5256512-A Gloss, image quality, durability CANON KABUSHIKI KAISHA (JP) 1993-10-26 US claimed
EP-0275636-B1 COLOR TONER AND TWO-COMPONENT DEVELOPER CONTAINING SAME CANON KABUSHIKI KAISHA (JP) 1993-07-21 EP claimed
EP-0243304-B1 SURFACE MODIFIED PIGMENT COMPOSITIONS CIBA-GEIGY AG (CH) 1993-06-02 EP claimed
US-5149610-A Color toner and two-component developer containing same CANON KABUSHIKI KAISHA (JP) 1992-09-22 US claimed
US-5145524-A With polymethyl vinyl ether; automotive and other finishes CIBA-GEIGY CORPORATION (US) 1992-09-08 US claimed
JP-63170659-A None JP disclosed
JP-63170657-A None JP disclosed
US-20130165446-A1 BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE HORIKOSHI, HIROYOSHI (CA) 2013-06-27 US disclosed
EP-2581373-A1 BENZO- OR PYRIDO-IMIDAZOLE DERIVATIVE Fujita, Takashi (JP) 2013-04-17 EP disclosed
EP-0990954-B1 Resin-coated carrier, two component type developer, and developing method CANON KK (JP) 2007-01-24 EP disclosed
EP-1130065-B1 Pigment compositions, production process thereof; colorants; and colored articles DAINICHISEIKA COLOR CHEM (JP) 2006-03-08 EP disclosed
EP-0332428-A2 Image forming method CANON KABUSHIKI KAISHA (JP) 1989-09-13 EP disclosed
US-4839255-A IMPACTING MODIFIER TO BASE PARTICLES CANON KABUSHIKI KAISHA (JP) 1989-06-13 US disclosed
EP-0285140-A2 Process for producing toner for developing electrostatic images CANON KABUSHIKI KAISHA (JP) 1988-10-05 EP disclosed
EP-0275636-A2 Color toner and two-component developer containing same CANON KABUSHIKI KAISHA (JP) 1988-07-27 EP disclosed
JP-S63170657-A TONER FOR ELECTRON PHOTOGRAPHY CANON INC 1988-07-14 JP disclosed
JP-S63170659-A TONER FOR ELECTRON PHOTOGRAPHY CANON INC 1988-07-14 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165446-A1 BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE PPARG, PPARA, PPARD NPC1 3730/4885RAB9A 3221/4885ALOX15 896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.